Overview

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-10-30
Target enrollment:
Participant gender:
Summary
This study proposes to compare a low-dose versus a high-dose buprenorphine induction scheme in 40 fentanyl using people with Opioid Use Disorder (OUD). Study participants will be randomized to either the low-dose (n=20) or high dose (n=20) group and dispensed medication daily for one week.
Phase:
PHASE4
Details
Lead Sponsor:
Friends Research Institute, Inc.
Collaborator:
MATClinics
Treatments:
Buprenorphine, Naloxone Drug Combination